Publications by authors named "Chanping You"

Claim this Profile
B
BQ323636.1 Employs the AR-CCRK Axis to Modulate the Expression of KU70 to Interfere with Non-Homologous End Joining Mediated DNA Repair Mechanism.
Ho Tsoi, Zi-Qing So, Ellen P S Man, Chan-Ping You, Koei Ho-Lam Cheung

Cells· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Splice Variant of the NCOR2 Gene BQ323636.1 Modulates ACSL4 Expression to Enhance Fatty Acid Metabolism and Support of Tumor Growth in Breast Cancer.
Ho Tsoi, Chan-Ping You, Koei Ho-Lam Cheung, Yin-Suen Tse, Ui-Soon Khoo

Int J Mol Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of BQ323636.1 contributes to anastrozole resistance in AR+ve/ER+ve breast cancer.
Ho Tsoi, Johann Lok, Ellen Ps Man, Cheuk-Nam Cheng, Man-Hong Leung, Chan-Ping You

J Pathol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SRSF5 Regulates the Expression of BQ323636.1 to Modulate Tamoxifen Resistance in ER-Positive Breast Cancer.
Ho Tsoi, Nicholas Nok-Ching Fung, Ellen P S Man, Man-Hong Leung, Chan-Ping You

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latent membrane protein 1 and macrophage-derived TNFα synergistically activate and mobilize invadopodia to drive invasion of nasopharyngeal carcinoma.
Wing Chung Tang, Sai Wah Tsao, Gareth E Jones, Xiong Liu, Ming Han Tsai, Chanping You

J Pathol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulating the Activity of Androgen Receptor for Treating Breast Cancer.
Chan-Ping You, Ho Tsoi, Ellen P S Man, Man-Hong Leung, Ui-Soon Khoo

Int J Mol Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer.
Ho Tsoi, Wai-Chung Tsang, Ellen P S Man, Man-Hong Leung, Chan-Ping You

Int J Mol Sci· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EBV Infection and Its Regulated Metabolic Reprogramming in Nasopharyngeal Tumorigenesis.
Tingting Yang, Chanping You, Shuhui Meng, Zhengquan Lai, Weipeng Ai

Front Cell Infect Microbiol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Ribosome Biogenesis to Combat Tamoxifen Resistance in ER+ve Breast Cancer.
Ho Tsoi, Chan-Ping You, Man-Hong Leung, Ellen P S Man, Ui-Soon Khoo

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen Receptor as an Emerging Feasible Biomarker for Breast Cancer.
Chan-Ping You, Man-Hong Leung, Wai-Chung Tsang, Ui-Soon Khoo, Ho Tsoi

Biomolecules· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic evaluation of palbociclib and its compatibility with other chemotherapies for primary and recurrent nasopharyngeal carcinoma.
Zhichao Xue, Vivian Wai Yan Lui, Yongshu Li, Lin Jia, Chanping You

J Exp Clin Cancer Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mTORC2-mediated PDHE1α nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma.
Jun Zhang, Lin Jia, Tengfei Liu, Yim Ling Yip, Wing Chung Tang, Chanping You

Oncogene· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis